In general, mitochondrial fission facilitates metastasis and drug resistance of cancer cells [49,50] and the inhibition of DRP1-mediated mitochondrial fission sensitizes ovarian cancer cells to cisplatin [51]. This evidence concerns the gene DNM1L and ovarian carcinoma.